The diagnosis and management of mild cognitive impairment: a clinical review.

IMPORTANCE Cognitive decline is a common and feared aspect of aging. Mild cognitive impairment (MCI) is defined as the symptomatic predementia stage on the continuum of cognitive decline, characterized by objective impairment in cognition that is not severe enough to require help with usual activities of daily living. OBJECTIVE To present evidence on the diagnosis, treatment, and prognosis of MCI and to provide physicians with an evidence-based framework for caring for older patients with MCI and their caregivers. EVIDENCE ACQUISITION We searched PubMed for English-language articles in peer-reviewed journals and the Cochrane Library database from inception through July 2014. Relevant references from retrieved articles were also evaluated. FINDINGS The prevalence of MCI in adults aged 65 years and older is 10% to 20%; risk increases with age and men appear to be at higher risk than women. In older patients with MCI, clinicians should consider depression, polypharmacy, and uncontrolled cardiovascular risk factors, all of which may increase risk for cognitive impairment and other negative outcomes. Currently, no medications have proven effective for MCI; treatments and interventions should be aimed at reducing cardiovascular risk factors and prevention of stroke. Aerobic exercise, mental activity, and social engagement may help decrease risk of further cognitive decline. Although patients with MCI are at greater risk for developing dementia compared with the general population, there is currently substantial variation in risk estimates (from <5% to 20% annual conversion rates), depending on the population studied. Current research targets improving early detection and treatment of MCI, particularly in patients at high risk for progression to dementia. CONCLUSIONS AND RELEVANCE Cognitive decline and MCI have important implications for patients and their families and will require that primary care clinicians be skilled in identifying and managing this common disorder as the number of older adults increases in coming decades. Current evidence supports aerobic exercise, mental activity, and cardiovascular risk factor control in patients with MCI.

[1]  M. Glymour,et al.  Effects of social integration on preserving memory function in a nationally representative US elderly population. , 2008, American journal of public health.

[2]  N. Pimlott,et al.  Developing physician consensus on the reporting of patients with mild cognitive impairment and mild dementia to transportation authorities in a region with mandatory reporting legislation. , 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[3]  J. Bosch,et al.  Use of ramipril in preventing stroke: double blind randomised trial , 2002, BMJ : British Medical Journal.

[4]  S. Salloway,et al.  Efficacy of donepezil in mild cognitive impairment , 2004, Neurology.

[5]  D. Carr,et al.  The older adult driver with cognitive impairment: "It's a very frustrating life". , 2010, JAMA.

[6]  C. Jack,et al.  Mild cognitive impairment due to Alzheimer disease in the community , 2013, Annals of neurology.

[7]  S. Ancoli-Israel,et al.  Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. , 2011, Journal of the American Medical Association (JAMA).

[8]  T. J. Grabowski,et al.  Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia , 2007 .

[9]  Joseph T. Hanlon,et al.  Managing Medications in Clinically Complex Elders , 2016 .

[10]  M. Fornage,et al.  Guidelines for the Primary Prevention of Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[11]  Keith A. Johnson,et al.  Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging , 2013, Alzheimer's & Dementia.

[12]  J. Hanlon,et al.  Managing medications in clinically complex elders: "There's got to be a happy medium". , 2010, JAMA.

[13]  Sterling C. Johnson,et al.  Magnetic Resonance Imaging Characterization of Brain Structure and Function in Mild Cognitive Impairment: A Review , 2008, Journal of the American Geriatrics Society.

[14]  Sujuan Gao,et al.  Redefined Blood Pressure Variability Measure and Its Association With Mortality in Elderly Primary Care Patients , 2014, Hypertension.

[15]  J. Foster,et al.  Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease , 2011 .

[16]  J. Morling,et al.  Cholinesterase inhibitors for mild cognitive impairment. , 2012, The Cochrane database of systematic reviews.

[17]  Jennifer S Lin,et al.  Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force , 2013 .

[18]  Theresa M Beckie,et al.  American Heart Association Council on Cardiovascular and Stroke Nursing. , 2013, The Journal of cardiovascular nursing.

[19]  T. Handy,et al.  Resistance training promotes cognitive and functional brain plasticity in seniors with probable mild cognitive impairment. , 2012, Archives of internal medicine.

[20]  C. Brayne,et al.  Making Alzheimer's and dementia research fit for populations , 2012, The Lancet.

[21]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[22]  A. M. Clarfield,et al.  The decreasing prevalence of reversible dementias: an updated meta-analysis. , 2003, Archives of internal medicine.

[23]  Malaz A Boustani,et al.  Risk factors for the progression of mild cognitive impairment to dementia. , 2013, Clinics in geriatric medicine.

[24]  Glen E Duncan,et al.  Effects of aerobic exercise on mild cognitive impairment: a controlled trial. , 2010, Archives of neurology.

[25]  R. Blendon,et al.  Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease , 2013, Alzheimer's Research & Therapy.

[26]  K. Hall,et al.  Optimal Blood Pressure for Cognitive Function: Findings from an Elderly African‐American Cohort Study , 2013, Journal of the American Geriatrics Society.

[27]  D. Devanand,et al.  Functional impairment in elderly patients with mild cognitive impairment and mild Alzheimer disease. , 2011, Archives of general psychiatry.

[28]  Paul M Thompson,et al.  Current and future uses of neuroimaging for cognitively impaired patients , 2008, The Lancet Neurology.

[29]  C. Lamoth,et al.  Gait and cognition: the relationship between gait stability and variability with executive function in persons with and without dementia. , 2012, Gait & posture.

[30]  Thomas D Koepsell,et al.  Reversion from mild cognitive impairment to normal or near-normal cognition , 2012, Neurology.

[31]  A. Meta-analysis.  The Decreasing Prevalence of Reversible Dementias , 2016 .

[32]  Takao Suzuki,et al.  Effects of multicomponent exercise on cognitive function in older adults with amnestic mild cognitive impairment: a randomized controlled trial , 2012, BMC Neurology.

[33]  D. Marson,et al.  Finances in the older patient with cognitive impairment: "He didn't want me to take over". , 2011, JAMA.

[34]  C. Clark,et al.  Performance of the Dementia Severity Rating Scale: A Caregiver Questionnaire for Rating Severity in Alzheimer Disease , 1996, Alzheimer disease and associated disorders.

[35]  N. Sattar,et al.  Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study , 2013, BMJ.

[36]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[37]  R. Petersen.  Clinical practice. Mild cognitive impairment. , 2011, The New England journal of medicine.

[38]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[39]  R. Coleman,et al.  Use of florbetapir-PET for imaging beta-amyloid pathology. , 2011, JAMA.

[40]  Jackson T. Wright,et al.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.

[41]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[42]  S. Zanotti-Cavazzoni.  Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis , 2011 .

[43]  Arthur F Kramer,et al.  The mental activity and exercise (MAX) trial: A randomized, controlled trial to enhance cognitive function in older adults with cognitive complaints , 2010, Alzheimer's & Dementia.

[44]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[45]  D. Grobbee,et al.  Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. , 2008, JAMA.

[46]  Nick C Fox,et al.  Revising the definition of Alzheimer's disease: a new lexicon , 2010, The Lancet Neurology.

[47]  J. Tuomilehto,et al.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.

[48]  A. Baskys,et al.  Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: A double-blind placebo-controlled study , 2005, American journal of Alzheimer's disease and other dementias.

[49]  R. Kessels,et al.  Group Therapy for Patients with Mild Cognitive Impairment and Their Significant Others: Results of a Waiting-List Controlled Trial , 2010, Gerontology.

[50]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[51]  T. Kurosaki,et al.  Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.

[52]  Dan Mungas,et al.  Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. , 2009, Archives of neurology.

[53]  C. Brayne,et al.  Political drive to screen for pre-dementia: not evidence based and ignores the harms of diagnosis , 2013, BMJ : British Medical Journal.

[54]  Nick C Fox,et al.  The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .

[55]  M. Boustani,et al.  Long-term anticholinergic use and the aging brain , 2013, Alzheimer's & Dementia.

[56]  G. Jackson,et al.  Integrated multidisciplinary diagnostic approach for dementia. , 2008, The British journal of psychiatry : the journal of mental science.

[57]  R. Petersen,et al.  Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice. , 2009, JAMA.

[58]  Jeffrey M. Hausdorff,et al.  Gait and Cognition: A Complementary Approach to Understanding Brain Function and the Risk of Falling , 2012, Journal of the American Geriatrics Society.

[59]  W. M. van der Flier,et al.  CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. , 2009, JAMA.

[60]  J. McCarten.  Clinical evaluation of early cognitive symptoms. , 2013, Clinics in geriatric medicine.

[61]  C. Jack,et al.  Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease , 2009, Brain : a journal of neurology.

[62]  P. Rothwell,et al.  Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis , 2010, The Lancet.

[63]  James A. Mortimer,et al.  Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply , 1997 .

[64]  A. Mitchell,et al.  Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies , 2009, Acta psychiatrica Scandinavica.

[65]  J. Foster,et al.  Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. , 2008, JAMA.

[66]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[67]  Kristine Yaffe,et al.  Sleep disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women , 2010, Alzheimer's & Dementia.

[68]  Luigi Ferrucci,et al.  Hearing loss and cognitive decline in older adults: questions and answers , 2014, Aging Clinical and Experimental Research.

[69]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[70]  C. Bulpitt,et al.  Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial , 2008, The Lancet Neurology.

[71]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[72]  D. Rujescu,et al.  Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study. , 2011, Journal of Alzheimer's disease : JAD.

[73]  R. Kessels,et al.  Learning to Live With a Loved One With Mild Cognitive Impairment , 2013, American journal of Alzheimer's disease and other dementias.

[74]  Anthony F Jorm.  A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation , 1994, Psychological Medicine.

[75]  J. Bond,et al.  Two‐Year Progression from Mild Cognitive Impairment to Dementia: To What Extent Do Different Definitions Agree? , 2008, Journal of the American Geriatrics Society.

[76]  K. Langa,et al.  Untreated poor vision: a contributing factor to late-life dementia. , 2010, American journal of epidemiology.

[77]  E. Simonsick,et al.  Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. , 2013, JAMA internal medicine.

[78]  J. Dungan.  Ginkgo biloba for Preventing Cognitive Decline in Older Adults: A Randomized Trial , 2010 .

[79]  P. Visser,et al.  Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[80]  Steven G Heeringa,et al.  Prevalence of Cognitive Impairment without Dementia in the United States , 2008, Annals of Internal Medicine.

[81]  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study , 2004 .

[82]  J P Miller,et al.  The AD8 , 2005, Neurology.

[83]  E G Tangalos,et al.  Prevalence of mild cognitive impairment is higher in men , 2010, Neurology.

[84]  C. DeCarli,et al.  Computer-based Cognitive Training for Mild Cognitive Impairment: Results from a Pilot Randomized, Controlled Trial , 2009, Alzheimer disease and associated disorders.

[85]  S. Salloway,et al.  Donepezil treatment of patients with MCI , 2009, Neurology.

[86]  E. Tangalos,et al.  CME Practice parameter: , 2022 .

[87]  Virginie Rondeau,et al.  Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. , 2009, JAMA.

[88]  Mike Martin,et al.  Cognition-based interventions for healthy older people and people with mild cognitive impairment. , 2011, The Cochrane database of systematic reviews.

[89]  L. Thal,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.

[90]  Godfrey Pearlson,et al.  Average Daily Blood Pressure, Not Office Blood Pressure, Is Associated With Progression of Cerebrovascular Disease and Cognitive Decline in Older People , 2011, Circulation.

[91]  Tracey Holsinger,et al.  Does this patient have dementia? , 2007, JAMA.

[92]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[93]  D. Bennett,et al.  Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.

[94]  Keith A. Johnson,et al.  Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer’s disease , 2011, Alzheimer's & Dementia.

[95]  S. Leurgans,et al.  The neuropathology of probable Alzheimer disease and mild cognitive impairment , 2009, Annals of neurology.

[96]  David S Knopman,et al.  Utility of the Functional Activities Questionnaire for Distinguishing Mild Cognitive Impairment From Very Mild Alzheimer Disease , 2010, Alzheimer disease and associated disorders.

[97]  David R. Roalf,et al.  Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging , 2013, Alzheimer's & Dementia.

[98]  Henri A. Vrooman,et al.  Progression of Cerebral Small Vessel Disease in Relation to Risk Factors and Cognitive Consequences: Rotterdam Scan Study , 2008, Stroke.